WENDY KING: Open Payments
NPI 1700366655 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $38 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| EMD Serono, Inc. | 2 | $63 |
| ARGENX US, INC. | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
Products named: KESIMPTA, Nayzilam, VYVGART HYTRULO, ACTHAR, Xeomin, Rystiggo.
Industry payments across LA — which companies pay providers there.
